Qi et al. confirmed that yeast-derived β–glucan activated dendritic cells (DCs) and macrophages via a C–type lectin receptor dectin–1 pathway, which could trigger effective anti-tumor immune response and notably down regulate immunosuppressive cells, resulting in delayed tumor progression [58]. Here, CLEC7A is linked to neoplasm.